Balyasny Asset Management
AGL icon

Balyasny Asset Management’s Agilon Health AGL Stock Holding History

Balyasny Asset Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,231
Closed -$107K – 2830
2025
Q4 		$107K Sell
6,231
-5,507
-47% -$107K ﹤0.01% 2950
2025
Q3 		$302K Buy
11,738
+8,254
+237% +$312K ﹤0.01% 2574
2025
Q2 		$200K Buy
3,484
+1,917
+122% +$154K ﹤0.01% 2594
2025
Q1 		$170K Buy
+1,567
New +$136K ﹤0.01% 2619
2024
Q4 		– Sell
-6,757
Closed -$664K – 2684
2024
Q3 		$664K Buy
+6,757
New +$872K ﹤0.01% 2142
2024
Q2 		– Sell
-23,685
Closed -$3.61M – 2524
2024
Q1 		$3.61M Buy
+23,685
New +$3.94M 0.01% 1344
2021
Q3 		– Sell
-580
Closed -$588K – 1897
2021
Q2 		$588K Buy
+580
New +$508K ﹤0.01% 1495

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return